Baseimmune was founded in 2019 by Joshua Blight and Ariana Gomes, who met during their PHDs at the Jenner Institute, University of Oxford, and software engineer Phillip Kemlo. The technology is based on a computational platform deciphering pathogen evolution to design cross-protective vaccines.
By using big data and a design algorithm, Baseimmune has been able to shorten the time it takes to develop a vaccine candidate. The antigen designs can be fed into any vaccine technology platform, including mRNA, DNA and viral vectors, to create universal “future-proof” vaccines engineered to be effective against current and potentially emerging variants.